HOME >> BIOLOGY >> NEWS
New prime-boost HIV vaccine strategy shows promise in monkeys

ter vaccination and then infected all the macaques with a high dose of SHIV. "Most other studies challenge after several weeks," says Dr. Moss, "but a vaccine that only protects for a short time is not very helpful. We extended the post-vaccination time to check long-term efficacy." Dr. Moss also stresses another important feature of their vaccine strategy: the monkeys were infected by applying the virus in the rectum. "The majority of HIV infections occur when the virus crosses mucous membranes, so we needed to see if our vaccine would work against this route of infection."

Although all 28 monkeys were infected, the vaccinated monkeys showed lower initial SHIV levels and quickly began to suppress the virus further. Twenty weeks after infection, the amount of virus in the bloodstream of the vaccinated monkeys was on average 2,000 times lower than controls. The researchers continue to monitor virus levels in these animals.

"These are among the very best outcomes we have seen in an animal model," says Peggy Johnston, Ph.D., NIAID's assistant director for HIV vaccines, "and we are using NIH's developmental resources and the HIV Vaccine Trials Network (HVTN) to move these and other promising vaccines into human trials in the United States and elsewhere as quickly as possible."

Both teams have already constructed HIV versions of the DNA and MVA vaccines, and human clinical trials are currently planned for the coming year. The rapid progress of these products and their future entry into clinical trials is being supported by NIAID through a range of programs put into place to fast-track HIV vaccines through the various stages of basic and preclinical research, product development and production, and clinical trials.


'"/>

Contact: Gregory Roa
greg.roa@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
7-Mar-2001


Page: 1 2 3

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows
3. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Protective gene may enhance vaccine responses
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. New glycan arrays discover autoimmunogenic activities of SARS-CoV: concern over monkey vaccine
8. Growing new breed of vaccine-producing plants to fight human diseases worldwide
9. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
10. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
11. Herpes tool allows researchers to customize Alzheimers vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
Breaking Biology Technology:
Cached News: